nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—PPARG—systemic lupus erythematosus	0.358	1	CbGaD
Telmisartan—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.0653	0.143	CbGbCtD
Telmisartan—ABCG2—Leflunomide—systemic lupus erythematosus	0.0489	0.107	CbGbCtD
Telmisartan—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.0334	0.0732	CbGbCtD
Telmisartan—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0302	0.0662	CbGbCtD
Telmisartan—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.0262	0.0574	CbGbCtD
Telmisartan—ABCC2—Cyclosporine—systemic lupus erythematosus	0.0253	0.0555	CbGbCtD
Telmisartan—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0242	0.0531	CbGbCtD
Telmisartan—ABCG2—Cyclosporine—systemic lupus erythematosus	0.0229	0.0502	CbGbCtD
Telmisartan—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0167	0.0365	CbGbCtD
Telmisartan—CYP2C19—Dapsone—systemic lupus erythematosus	0.0156	0.0341	CbGbCtD
Telmisartan—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0151	0.033	CbGbCtD
Telmisartan—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0144	0.0315	CbGbCtD
Telmisartan—ABCC2—Methotrexate—systemic lupus erythematosus	0.0134	0.0294	CbGbCtD
Telmisartan—ABCG2—Methotrexate—systemic lupus erythematosus	0.0121	0.0266	CbGbCtD
Telmisartan—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0109	0.0239	CbGbCtD
Telmisartan—CYP2C19—Prednisone—systemic lupus erythematosus	0.0108	0.0237	CbGbCtD
Telmisartan—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0102	0.0224	CbGbCtD
Telmisartan—ABCB1—Betamethasone—systemic lupus erythematosus	0.00935	0.0205	CbGbCtD
Telmisartan—ABCB1—Prednisolone—systemic lupus erythematosus	0.00922	0.0202	CbGbCtD
Telmisartan—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00874	0.0192	CbGbCtD
Telmisartan—ABCB1—Prednisone—systemic lupus erythematosus	0.00871	0.0191	CbGbCtD
Telmisartan—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00826	0.0181	CbGbCtD
Telmisartan—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00674	0.0148	CbGbCtD
Telmisartan—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00544	0.0119	CbGbCtD
Telmisartan—ABCB1—Methotrexate—systemic lupus erythematosus	0.00437	0.00957	CbGbCtD
Telmisartan—CYP2C19—urine—systemic lupus erythematosus	0.00222	0.0761	CbGeAlD
Telmisartan—AGTR1—endothelium—systemic lupus erythematosus	0.0021	0.072	CbGeAlD
Telmisartan—AGTR1—blood plasma—systemic lupus erythematosus	0.00187	0.0639	CbGeAlD
Telmisartan—PPARG—endothelium—systemic lupus erythematosus	0.00173	0.0592	CbGeAlD
Telmisartan—PPARG—blood plasma—systemic lupus erythematosus	0.00154	0.0526	CbGeAlD
Telmisartan—CYP2C19—blood plasma—systemic lupus erythematosus	0.00116	0.0397	CbGeAlD
Telmisartan—AGTR1—connective tissue—systemic lupus erythematosus	0.000994	0.034	CbGeAlD
Telmisartan—SLCO1B3—lung—systemic lupus erythematosus	0.000988	0.0338	CbGeAlD
Telmisartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.000963	0.033	CbGeAlD
Telmisartan—AGTR1—kidney—systemic lupus erythematosus	0.000846	0.029	CbGeAlD
Telmisartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.000824	0.0282	CbGeAlD
Telmisartan—PPARG—connective tissue—systemic lupus erythematosus	0.000817	0.028	CbGeAlD
Telmisartan—PPARG—skin of body—systemic lupus erythematosus	0.000738	0.0253	CbGeAlD
Telmisartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.000727	0.0249	CbGeAlD
Telmisartan—ABCC2—nephron tubule—systemic lupus erythematosus	0.000696	0.0238	CbGeAlD
Telmisartan—PPARG—kidney—systemic lupus erythematosus	0.000696	0.0238	CbGeAlD
Telmisartan—AGTR1—tendon—systemic lupus erythematosus	0.000683	0.0234	CbGeAlD
Telmisartan—ABCC2—kidney—systemic lupus erythematosus	0.000612	0.0209	CbGeAlD
Telmisartan—AGTR1—lung—systemic lupus erythematosus	0.0006	0.0205	CbGeAlD
Telmisartan—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000598	0.0205	CbGeAlD
Telmisartan—ABCC2—cortex of kidney—systemic lupus erythematosus	0.000596	0.0204	CbGeAlD
Telmisartan—PPARG—tendon—systemic lupus erythematosus	0.000562	0.0192	CbGeAlD
Telmisartan—AGTR1—nervous system—systemic lupus erythematosus	0.000555	0.019	CbGeAlD
Telmisartan—PPARG—bone marrow—systemic lupus erythematosus	0.000544	0.0186	CbGeAlD
Telmisartan—AGTR1—central nervous system—systemic lupus erythematosus	0.000535	0.0183	CbGeAlD
Telmisartan—ABCG2—nephron tubule—systemic lupus erythematosus	0.000508	0.0174	CbGeAlD
Telmisartan—ABCC2—tendon—systemic lupus erythematosus	0.000494	0.0169	CbGeAlD
Telmisartan—PPARG—lung—systemic lupus erythematosus	0.000493	0.0169	CbGeAlD
Telmisartan—ABCB1—blood plasma—systemic lupus erythematosus	0.000485	0.0166	CbGeAlD
Telmisartan—PPARG—nervous system—systemic lupus erythematosus	0.000457	0.0156	CbGeAlD
Telmisartan—PPARG—central nervous system—systemic lupus erythematosus	0.00044	0.015	CbGeAlD
Telmisartan—ABCG2—bone marrow—systemic lupus erythematosus	0.000349	0.0119	CbGeAlD
Telmisartan—ABCG2—lung—systemic lupus erythematosus	0.000316	0.0108	CbGeAlD
Telmisartan—Losartan—ACE—systemic lupus erythematosus	0.000251	0.709	CrCbGaD
Telmisartan—ABCB1—nephron tubule—systemic lupus erythematosus	0.00025	0.00857	CbGeAlD
Telmisartan—ABCB1—kidney—systemic lupus erythematosus	0.00022	0.00753	CbGeAlD
Telmisartan—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000214	0.00733	CbGeAlD
Telmisartan—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000189	0.00647	CbGeAlD
Telmisartan—ABCB1—bone marrow—systemic lupus erythematosus	0.000172	0.00589	CbGeAlD
Telmisartan—ABCB1—lung—systemic lupus erythematosus	0.000156	0.00533	CbGeAlD
Telmisartan—ABCB1—nervous system—systemic lupus erythematosus	0.000144	0.00494	CbGeAlD
Telmisartan—ABCB1—central nervous system—systemic lupus erythematosus	0.000139	0.00476	CbGeAlD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000123	0.00385	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000123	0.00384	CbGpPWpGaD
Telmisartan—PPARG—PPARA activates gene expression—RXRA—systemic lupus erythematosus	0.000122	0.00382	CbGpPWpGaD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	0.00012	0.00374	CbGpPWpGaD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	0.00012	0.00374	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	0.000119	0.00372	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000116	0.00364	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—systemic lupus erythematosus	0.000114	0.00356	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000112	0.00349	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000111	0.00348	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IFNG—systemic lupus erythematosus	0.000111	0.00346	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—RXRA—systemic lupus erythematosus	0.000107	0.00334	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	0.000106	0.0033	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000104	0.00325	CbGpPWpGaD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—systemic lupus erythematosus	0.000103	0.00323	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000103	0.00323	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000103	0.00321	CbGpPWpGaD
Telmisartan—Losartan—ALB—systemic lupus erythematosus	0.000103	0.291	CrCbGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000103	0.00321	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—IL2—systemic lupus erythematosus	9.85e-05	0.00308	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	9.42e-05	0.00294	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	9.35e-05	0.00292	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	8.94e-05	0.00279	CbGpPWpGaD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	8.92e-05	0.00279	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	8.8e-05	0.00275	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—NR3C1—systemic lupus erythematosus	8.72e-05	0.00272	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1B—systemic lupus erythematosus	8.65e-05	0.0027	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	8.45e-05	0.00264	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—FAS—systemic lupus erythematosus	8.44e-05	0.00264	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	8.43e-05	0.00263	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—systemic lupus erythematosus	8.37e-05	0.00261	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	8.27e-05	0.00258	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	8.25e-05	0.00258	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	8.24e-05	0.00257	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—RXRA—systemic lupus erythematosus	8.17e-05	0.00255	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	8.14e-05	0.00254	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	8.07e-05	0.00252	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.02e-05	0.0025	CbGpPWpGaD
Telmisartan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	8e-05	0.0025	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—CDKN1A—systemic lupus erythematosus	7.98e-05	0.00249	CbGpPWpGaD
Telmisartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	7.78e-05	0.00243	CbGpPWpGaD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	7.7e-05	0.00241	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—systemic lupus erythematosus	7.68e-05	0.0024	CbGpPWpGaD
Telmisartan—PPARG—Regulation of retinoblastoma protein—EP300—systemic lupus erythematosus	7.6e-05	0.00237	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	7.56e-05	0.00236	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	7.34e-05	0.00229	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	7.3e-05	0.00228	CbGpPWpGaD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—EP300—systemic lupus erythematosus	7.25e-05	0.00226	CbGpPWpGaD
Telmisartan—AGTR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	7.25e-05	0.00226	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	7.22e-05	0.00225	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TNF—systemic lupus erythematosus	7.17e-05	0.00224	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	7.11e-05	0.00222	CbGpPWpGaD
Telmisartan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	6.79e-05	0.000548	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	6.78e-05	0.000547	CcSEcCtD
Telmisartan—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.78e-05	0.000546	CcSEcCtD
Telmisartan—Urethral disorder—Methotrexate—systemic lupus erythematosus	6.74e-05	0.000543	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	6.74e-05	0.000543	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	6.73e-05	0.000542	CcSEcCtD
Telmisartan—Pain—Hydrocortisone—systemic lupus erythematosus	6.72e-05	0.000542	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	6.71e-05	0.0021	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	6.71e-05	0.000541	CcSEcCtD
Telmisartan—Oedema—Dexamethasone—systemic lupus erythematosus	6.71e-05	0.000541	CcSEcCtD
Telmisartan—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	6.71e-05	0.000541	CcSEcCtD
Telmisartan—Oedema—Betamethasone—systemic lupus erythematosus	6.71e-05	0.000541	CcSEcCtD
Telmisartan—Insomnia—Triamcinolone—systemic lupus erythematosus	6.69e-05	0.000539	CcSEcCtD
Telmisartan—Insomnia—Methylprednisolone—systemic lupus erythematosus	6.68e-05	0.000538	CcSEcCtD
Telmisartan—Infection—Betamethasone—systemic lupus erythematosus	6.67e-05	0.000538	CcSEcCtD
Telmisartan—Infection—Dexamethasone—systemic lupus erythematosus	6.67e-05	0.000538	CcSEcCtD
Telmisartan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	6.65e-05	0.000536	CcSEcCtD
Telmisartan—Paraesthesia—Triamcinolone—systemic lupus erythematosus	6.64e-05	0.000536	CcSEcCtD
Telmisartan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	6.63e-05	0.000534	CcSEcCtD
Telmisartan—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	6.63e-05	0.000534	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—systemic lupus erythematosus	6.63e-05	0.000534	CcSEcCtD
Telmisartan—Anaemia—Prednisone—systemic lupus erythematosus	6.62e-05	0.000534	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	6.61e-05	0.00207	CbGpPWpGaD
Telmisartan—Shock—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000532	CcSEcCtD
Telmisartan—Shock—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000532	CcSEcCtD
Telmisartan—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.6e-05	0.000532	CcSEcCtD
Telmisartan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	6.58e-05	0.000531	CcSEcCtD
Telmisartan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	6.58e-05	0.000531	CcSEcCtD
Telmisartan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.57e-05	0.00053	CcSEcCtD
Telmisartan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.57e-05	0.00053	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	6.56e-05	0.00205	CbGpPWpGaD
Telmisartan—Tachycardia—Betamethasone—systemic lupus erythematosus	6.55e-05	0.000528	CcSEcCtD
Telmisartan—Tachycardia—Dexamethasone—systemic lupus erythematosus	6.55e-05	0.000528	CcSEcCtD
Telmisartan—Angioedema—Prednisone—systemic lupus erythematosus	6.55e-05	0.000528	CcSEcCtD
Telmisartan—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	6.51e-05	0.000525	CcSEcCtD
Telmisartan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	6.51e-05	0.000525	CcSEcCtD
Telmisartan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	6.5e-05	0.000524	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.5e-05	0.00203	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	6.49e-05	0.000523	CcSEcCtD
Telmisartan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	6.49e-05	0.000523	CcSEcCtD
Telmisartan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	6.48e-05	0.000522	CcSEcCtD
Telmisartan—Malaise—Prednisone—systemic lupus erythematosus	6.46e-05	0.000521	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	6.46e-05	0.00202	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SNRPD1—systemic lupus erythematosus	6.45e-05	0.00202	CbGpPWpGaD
Telmisartan—Vertigo—Prednisone—systemic lupus erythematosus	6.44e-05	0.000519	CcSEcCtD
Telmisartan—Eye disorder—Methotrexate—systemic lupus erythematosus	6.43e-05	0.000518	CcSEcCtD
Telmisartan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	6.43e-05	0.000518	CcSEcCtD
Telmisartan—Syncope—Prednisone—systemic lupus erythematosus	6.42e-05	0.000518	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—systemic lupus erythematosus	6.41e-05	0.000517	CcSEcCtD
Telmisartan—Anorexia—Dexamethasone—systemic lupus erythematosus	6.4e-05	0.000516	CcSEcCtD
Telmisartan—Anorexia—Betamethasone—systemic lupus erythematosus	6.4e-05	0.000516	CcSEcCtD
Telmisartan—Urticaria—Prednisolone—systemic lupus erythematosus	6.39e-05	0.000515	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—systemic lupus erythematosus	6.38e-05	0.000515	CcSEcCtD
Telmisartan—Fatigue—Triamcinolone—systemic lupus erythematosus	6.38e-05	0.000514	CcSEcCtD
Telmisartan—Fatigue—Methylprednisolone—systemic lupus erythematosus	6.37e-05	0.000513	CcSEcCtD
Telmisartan—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	6.36e-05	0.000512	CcSEcCtD
Telmisartan—Asthenia—Cyclosporine—systemic lupus erythematosus	6.34e-05	0.000511	CcSEcCtD
Telmisartan—Pain—Triamcinolone—systemic lupus erythematosus	6.33e-05	0.00051	CcSEcCtD
Telmisartan—Loss of consciousness—Prednisone—systemic lupus erythematosus	6.3e-05	0.000508	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	6.29e-05	0.00197	CbGpPWpGaD
Telmisartan—Hypotension—Betamethasone—systemic lupus erythematosus	6.27e-05	0.000506	CcSEcCtD
Telmisartan—Hypotension—Dexamethasone—systemic lupus erythematosus	6.27e-05	0.000506	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	6.26e-05	0.00196	CbGpPWpGaD
Telmisartan—Pruritus—Cyclosporine—systemic lupus erythematosus	6.26e-05	0.000504	CcSEcCtD
Telmisartan—Urticaria—Hydrocortisone—systemic lupus erythematosus	6.24e-05	0.000503	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—systemic lupus erythematosus	6.24e-05	0.000503	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—systemic lupus erythematosus	6.21e-05	0.000501	CcSEcCtD
Telmisartan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	6.21e-05	0.000501	CcSEcCtD
Telmisartan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	6.21e-05	0.000501	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	6.2e-05	0.0005	CcSEcCtD
Telmisartan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	6.19e-05	0.000499	CcSEcCtD
Telmisartan—Hypertension—Prednisone—systemic lupus erythematosus	6.19e-05	0.000499	CcSEcCtD
Telmisartan—Chills—Methotrexate—systemic lupus erythematosus	6.17e-05	0.000497	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	6.16e-05	0.00192	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	6.12e-05	0.000493	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	6.12e-05	0.000493	CcSEcCtD
Telmisartan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	6.1e-05	0.000492	CcSEcCtD
Telmisartan—Arthralgia—Prednisone—systemic lupus erythematosus	6.1e-05	0.000492	CcSEcCtD
Telmisartan—Myalgia—Prednisone—systemic lupus erythematosus	6.1e-05	0.000492	CcSEcCtD
Telmisartan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	6.1e-05	0.000492	CcSEcCtD
Telmisartan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	6.08e-05	0.00049	CcSEcCtD
Telmisartan—Anxiety—Prednisone—systemic lupus erythematosus	6.08e-05	0.00049	CcSEcCtD
Telmisartan—Insomnia—Dexamethasone—systemic lupus erythematosus	6.07e-05	0.000489	CcSEcCtD
Telmisartan—Insomnia—Betamethasone—systemic lupus erythematosus	6.07e-05	0.000489	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.07e-05	0.0019	CbGpPWpGaD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	6.06e-05	0.000488	CcSEcCtD
Telmisartan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	6.05e-05	0.000488	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	6.04e-05	0.000487	CcSEcCtD
Telmisartan—Paraesthesia—Dexamethasone—systemic lupus erythematosus	6.03e-05	0.000486	CcSEcCtD
Telmisartan—Paraesthesia—Betamethasone—systemic lupus erythematosus	6.03e-05	0.000486	CcSEcCtD
Telmisartan—Discomfort—Prednisone—systemic lupus erythematosus	6.03e-05	0.000486	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—systemic lupus erythematosus	6.03e-05	0.000486	CcSEcCtD
Telmisartan—Erythema—Methotrexate—systemic lupus erythematosus	5.99e-05	0.000483	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—systemic lupus erythematosus	5.99e-05	0.000483	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—FAS—systemic lupus erythematosus	5.96e-05	0.00186	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisolone—systemic lupus erythematosus	5.93e-05	0.000478	CcSEcCtD
Telmisartan—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.91e-05	0.000476	CcSEcCtD
Telmisartan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.91e-05	0.000476	CcSEcCtD
Telmisartan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.9e-05	0.000476	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—systemic lupus erythematosus	5.88e-05	0.00184	CbGpPWpGaD
Telmisartan—Urticaria—Triamcinolone—systemic lupus erythematosus	5.88e-05	0.000474	CcSEcCtD
Telmisartan—Urticaria—Methylprednisolone—systemic lupus erythematosus	5.87e-05	0.000473	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000473	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	5.86e-05	0.00183	CbGpPWpGaD
Telmisartan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.85e-05	0.000472	CcSEcCtD
Telmisartan—Dizziness—Cyclosporine—systemic lupus erythematosus	5.85e-05	0.000471	CcSEcCtD
Telmisartan—Anaphylactic shock—Prednisone—systemic lupus erythematosus	5.85e-05	0.000471	CcSEcCtD
Telmisartan—Oedema—Prednisone—systemic lupus erythematosus	5.85e-05	0.000471	CcSEcCtD
Telmisartan—PPARG—Gene Expression—MTA2—systemic lupus erythematosus	5.84e-05	0.00182	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	5.84e-05	0.00182	CbGpPWpGaD
Telmisartan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.84e-05	0.00047	CcSEcCtD
Telmisartan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.84e-05	0.00047	CcSEcCtD
Telmisartan—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.84e-05	0.00047	CcSEcCtD
Telmisartan—Infection—Prednisone—systemic lupus erythematosus	5.81e-05	0.000468	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.8e-05	0.000467	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.8e-05	0.000467	CcSEcCtD
Telmisartan—Back pain—Methotrexate—systemic lupus erythematosus	5.79e-05	0.000467	CcSEcCtD
Telmisartan—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	5.79e-05	0.000467	CcSEcCtD
Telmisartan—Fatigue—Dexamethasone—systemic lupus erythematosus	5.79e-05	0.000467	CcSEcCtD
Telmisartan—Fatigue—Betamethasone—systemic lupus erythematosus	5.79e-05	0.000467	CcSEcCtD
Telmisartan—Shock—Prednisone—systemic lupus erythematosus	5.75e-05	0.000464	CcSEcCtD
Telmisartan—Pain—Betamethasone—systemic lupus erythematosus	5.74e-05	0.000463	CcSEcCtD
Telmisartan—Pain—Dexamethasone—systemic lupus erythematosus	5.74e-05	0.000463	CcSEcCtD
Telmisartan—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.73e-05	0.000462	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—systemic lupus erythematosus	5.71e-05	0.00046	CcSEcCtD
Telmisartan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.7e-05	0.00046	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—systemic lupus erythematosus	5.68e-05	0.000458	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	5.67e-05	0.00177	CbGpPWpGaD
Telmisartan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	5.65e-05	0.000456	CcSEcCtD
Telmisartan—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.64e-05	0.000454	CcSEcCtD
Telmisartan—Vomiting—Cyclosporine—systemic lupus erythematosus	5.62e-05	0.000453	CcSEcCtD
Telmisartan—Rash—Cyclosporine—systemic lupus erythematosus	5.58e-05	0.000449	CcSEcCtD
Telmisartan—Anorexia—Prednisone—systemic lupus erythematosus	5.57e-05	0.000449	CcSEcCtD
Telmisartan—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.57e-05	0.000449	CcSEcCtD
Telmisartan—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.56e-05	0.000448	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000448	CcSEcCtD
Telmisartan—Headache—Cyclosporine—systemic lupus erythematosus	5.54e-05	0.000447	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	5.54e-05	0.00173	CbGpPWpGaD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	5.54e-05	0.00173	CbGpPWpGaD
Telmisartan—Anaemia—Methotrexate—systemic lupus erythematosus	5.53e-05	0.000446	CcSEcCtD
Telmisartan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	5.53e-05	0.000446	CcSEcCtD
Telmisartan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	5.53e-05	0.000446	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	5.53e-05	0.00173	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	5.53e-05	0.00173	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.49e-05	0.000443	CcSEcCtD
Telmisartan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.49e-05	0.000443	CcSEcCtD
Telmisartan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.48e-05	0.000442	CcSEcCtD
Telmisartan—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	5.45e-05	0.000439	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	5.45e-05	0.0017	CbGpPWpGaD
Telmisartan—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	5.44e-05	0.000438	CcSEcCtD
Telmisartan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.44e-05	0.000438	CcSEcCtD
Telmisartan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.43e-05	0.000438	CcSEcCtD
Telmisartan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	5.4e-05	0.000436	CcSEcCtD
Telmisartan—Malaise—Methotrexate—systemic lupus erythematosus	5.4e-05	0.000435	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	5.38e-05	0.00168	CbGpPWpGaD
Telmisartan—Vertigo—Methotrexate—systemic lupus erythematosus	5.38e-05	0.000434	CcSEcCtD
Telmisartan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.38e-05	0.000433	CcSEcCtD
Telmisartan—Urticaria—Dexamethasone—systemic lupus erythematosus	5.33e-05	0.00043	CcSEcCtD
Telmisartan—Urticaria—Betamethasone—systemic lupus erythematosus	5.33e-05	0.00043	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	5.33e-05	0.000429	CcSEcCtD
Telmisartan—Dizziness—Prednisolone—systemic lupus erythematosus	5.32e-05	0.000429	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	5.31e-05	0.00166	CbGpPWpGaD
Telmisartan—Asthenia—Triamcinolone—systemic lupus erythematosus	5.31e-05	0.000428	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—LYN—systemic lupus erythematosus	5.31e-05	0.00166	CbGpPWpGaD
Telmisartan—Abdominal pain—Betamethasone—systemic lupus erythematosus	5.31e-05	0.000428	CcSEcCtD
Telmisartan—Body temperature increased—Betamethasone—systemic lupus erythematosus	5.31e-05	0.000428	CcSEcCtD
Telmisartan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	5.31e-05	0.000428	CcSEcCtD
Telmisartan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	5.31e-05	0.000428	CcSEcCtD
Telmisartan—Asthenia—Methylprednisolone—systemic lupus erythematosus	5.3e-05	0.000427	CcSEcCtD
Telmisartan—Insomnia—Prednisone—systemic lupus erythematosus	5.29e-05	0.000426	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	5.29e-05	0.00165	CbGpPWpGaD
Telmisartan—Nausea—Cyclosporine—systemic lupus erythematosus	5.25e-05	0.000423	CcSEcCtD
Telmisartan—Paraesthesia—Prednisone—systemic lupus erythematosus	5.25e-05	0.000423	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	5.25e-05	0.00164	CbGpPWpGaD
Telmisartan—Pruritus—Triamcinolone—systemic lupus erythematosus	5.24e-05	0.000422	CcSEcCtD
Telmisartan—Cough—Methotrexate—systemic lupus erythematosus	5.22e-05	0.000421	CcSEcCtD
Telmisartan—Pruritus—Methylprednisolone—systemic lupus erythematosus	5.22e-05	0.000421	CcSEcCtD
Telmisartan—Dizziness—Hydrocortisone—systemic lupus erythematosus	5.2e-05	0.000419	CcSEcCtD
Telmisartan—Dyspepsia—Prednisone—systemic lupus erythematosus	5.15e-05	0.000415	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	5.14e-05	0.00161	CbGpPWpGaD
Telmisartan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	5.12e-05	0.000413	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000411	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000411	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—systemic lupus erythematosus	5.1e-05	0.000411	CcSEcCtD
Telmisartan—Decreased appetite—Prednisone—systemic lupus erythematosus	5.08e-05	0.00041	CcSEcCtD
Telmisartan—Rash—Prednisolone—systemic lupus erythematosus	5.07e-05	0.000409	CcSEcCtD
Telmisartan—Dermatitis—Prednisolone—systemic lupus erythematosus	5.07e-05	0.000409	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	5.06e-05	0.000408	CcSEcCtD
Telmisartan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	5.05e-05	0.000407	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—EP300—systemic lupus erythematosus	5.05e-05	0.00158	CbGpPWpGaD
Telmisartan—Fatigue—Prednisone—systemic lupus erythematosus	5.04e-05	0.000406	CcSEcCtD
Telmisartan—Headache—Prednisolone—systemic lupus erythematosus	5.04e-05	0.000406	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—systemic lupus erythematosus	5.04e-05	0.000406	CcSEcCtD
Telmisartan—Constipation—Prednisone—systemic lupus erythematosus	5e-05	0.000403	CcSEcCtD
Telmisartan—Vomiting—Hydrocortisone—systemic lupus erythematosus	5e-05	0.000403	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	4.96e-05	0.00155	CbGpPWpGaD
Telmisartan—Rash—Hydrocortisone—systemic lupus erythematosus	4.95e-05	0.000399	CcSEcCtD
Telmisartan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.95e-05	0.000399	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	4.94e-05	0.00154	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	4.93e-05	0.00154	CbGpPWpGaD
Telmisartan—Headache—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.000397	CcSEcCtD
Telmisartan—Dizziness—Triamcinolone—systemic lupus erythematosus	4.89e-05	0.000394	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	4.89e-05	0.00153	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000394	CcSEcCtD
Telmisartan—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.88e-05	0.000394	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	4.86e-05	0.00152	CbGpPWpGaD
Telmisartan—Infection—Methotrexate—systemic lupus erythematosus	4.85e-05	0.000391	CcSEcCtD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	4.83e-05	0.00151	CbGpPWpGaD
Telmisartan—Feeling abnormal—Prednisone—systemic lupus erythematosus	4.82e-05	0.000388	CcSEcCtD
Telmisartan—Asthenia—Betamethasone—systemic lupus erythematosus	4.82e-05	0.000388	CcSEcCtD
Telmisartan—Asthenia—Dexamethasone—systemic lupus erythematosus	4.82e-05	0.000388	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	4.8e-05	0.0015	CbGpPWpGaD
Telmisartan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.79e-05	0.000386	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.78e-05	0.000386	CcSEcCtD
Telmisartan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.78e-05	0.000385	CcSEcCtD
Telmisartan—Nausea—Prednisolone—systemic lupus erythematosus	4.78e-05	0.000385	CcSEcCtD
Telmisartan—Pruritus—Dexamethasone—systemic lupus erythematosus	4.75e-05	0.000383	CcSEcCtD
Telmisartan—Pruritus—Betamethasone—systemic lupus erythematosus	4.75e-05	0.000383	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—systemic lupus erythematosus	4.75e-05	0.000383	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000381	CcSEcCtD
Telmisartan—Vomiting—Triamcinolone—systemic lupus erythematosus	4.7e-05	0.000379	CcSEcCtD
Telmisartan—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.69e-05	0.000378	CcSEcCtD
Telmisartan—Nausea—Hydrocortisone—systemic lupus erythematosus	4.67e-05	0.000376	CcSEcCtD
Telmisartan—Rash—Triamcinolone—systemic lupus erythematosus	4.67e-05	0.000376	CcSEcCtD
Telmisartan—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.66e-05	0.000376	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—systemic lupus erythematosus	4.66e-05	0.000375	CcSEcCtD
Telmisartan—Rash—Methylprednisolone—systemic lupus erythematosus	4.66e-05	0.000375	CcSEcCtD
Telmisartan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.65e-05	0.000375	CcSEcCtD
Telmisartan—Urticaria—Prednisone—systemic lupus erythematosus	4.64e-05	0.000374	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—CDKN1A—systemic lupus erythematosus	4.64e-05	0.00145	CbGpPWpGaD
Telmisartan—Headache—Triamcinolone—systemic lupus erythematosus	4.64e-05	0.000374	CcSEcCtD
Telmisartan—Headache—Methylprednisolone—systemic lupus erythematosus	4.63e-05	0.000373	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—systemic lupus erythematosus	4.62e-05	0.000373	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—systemic lupus erythematosus	4.62e-05	0.000373	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	4.61e-05	0.00144	CbGpPWpGaD
Telmisartan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.59e-05	0.00037	CcSEcCtD
Telmisartan—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.59e-05	0.00037	CcSEcCtD
Telmisartan—Hypotension—Methotrexate—systemic lupus erythematosus	4.57e-05	0.000368	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—PTPRC—systemic lupus erythematosus	4.54e-05	0.00142	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	4.45e-05	0.00139	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	4.45e-05	0.00139	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000359	CcSEcCtD
Telmisartan—Dizziness—Dexamethasone—systemic lupus erythematosus	4.44e-05	0.000358	CcSEcCtD
Telmisartan—Dizziness—Betamethasone—systemic lupus erythematosus	4.44e-05	0.000358	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—systemic lupus erythematosus	4.42e-05	0.000356	CcSEcCtD
Telmisartan—Nausea—Triamcinolone—systemic lupus erythematosus	4.4e-05	0.000354	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—systemic lupus erythematosus	4.39e-05	0.000354	CcSEcCtD
Telmisartan—Nausea—Methylprednisolone—systemic lupus erythematosus	4.39e-05	0.000354	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.36e-05	0.000351	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—systemic lupus erythematosus	4.34e-05	0.00035	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	4.33e-05	0.00135	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	4.33e-05	0.00135	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	4.31e-05	0.00135	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisone—systemic lupus erythematosus	4.31e-05	0.000347	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—systemic lupus erythematosus	4.3e-05	0.000347	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—ADIPOQ—systemic lupus erythematosus	4.29e-05	0.00134	CbGpPWpGaD
Telmisartan—Vomiting—Betamethasone—systemic lupus erythematosus	4.27e-05	0.000344	CcSEcCtD
Telmisartan—Vomiting—Dexamethasone—systemic lupus erythematosus	4.27e-05	0.000344	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—systemic lupus erythematosus	4.25e-05	0.000342	CcSEcCtD
Telmisartan—Rash—Betamethasone—systemic lupus erythematosus	4.23e-05	0.000341	CcSEcCtD
Telmisartan—Rash—Dexamethasone—systemic lupus erythematosus	4.23e-05	0.000341	CcSEcCtD
Telmisartan—Dermatitis—Betamethasone—systemic lupus erythematosus	4.23e-05	0.000341	CcSEcCtD
Telmisartan—Dermatitis—Dexamethasone—systemic lupus erythematosus	4.23e-05	0.000341	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	4.22e-05	0.00034	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—C3—systemic lupus erythematosus	4.22e-05	0.00132	CbGpPWpGaD
Telmisartan—Fatigue—Methotrexate—systemic lupus erythematosus	4.21e-05	0.00034	CcSEcCtD
Telmisartan—Headache—Betamethasone—systemic lupus erythematosus	4.21e-05	0.000339	CcSEcCtD
Telmisartan—Headache—Dexamethasone—systemic lupus erythematosus	4.21e-05	0.000339	CcSEcCtD
Telmisartan—Asthenia—Prednisone—systemic lupus erythematosus	4.2e-05	0.000338	CcSEcCtD
Telmisartan—Pain—Methotrexate—systemic lupus erythematosus	4.18e-05	0.000337	CcSEcCtD
Telmisartan—Pruritus—Prednisone—systemic lupus erythematosus	4.14e-05	0.000333	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	4.11e-05	0.00129	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.09e-05	0.00128	CbGpPWpGaD
Telmisartan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	4.03e-05	0.000325	CcSEcCtD
Telmisartan—Diarrhoea—Prednisone—systemic lupus erythematosus	4e-05	0.000322	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4e-05	0.000322	CcSEcCtD
Telmisartan—Nausea—Betamethasone—systemic lupus erythematosus	3.99e-05	0.000321	CcSEcCtD
Telmisartan—Nausea—Dexamethasone—systemic lupus erythematosus	3.99e-05	0.000321	CcSEcCtD
Telmisartan—PPARG—Gene Expression—TNFSF13—systemic lupus erythematosus	3.94e-05	0.00123	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	3.9e-05	0.00122	CbGpPWpGaD
Telmisartan—Urticaria—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000313	CcSEcCtD
Telmisartan—Dizziness—Prednisone—systemic lupus erythematosus	3.87e-05	0.000312	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000311	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.86e-05	0.000311	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.85e-05	0.0012	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TGFB1—systemic lupus erythematosus	3.84e-05	0.0012	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SNRPB—systemic lupus erythematosus	3.82e-05	0.00119	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.75e-05	0.00117	CbGpPWpGaD
Telmisartan—Vomiting—Prednisone—systemic lupus erythematosus	3.72e-05	0.0003	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—F2—systemic lupus erythematosus	3.7e-05	0.00116	CbGpPWpGaD
Telmisartan—Rash—Prednisone—systemic lupus erythematosus	3.69e-05	0.000297	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—systemic lupus erythematosus	3.68e-05	0.000297	CcSEcCtD
Telmisartan—PPARG—Developmental Biology—RXRA—systemic lupus erythematosus	3.67e-05	0.00115	CbGpPWpGaD
Telmisartan—Headache—Prednisone—systemic lupus erythematosus	3.66e-05	0.000295	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.66e-05	0.00114	CbGpPWpGaD
Telmisartan—Hypersensitivity—Methotrexate—systemic lupus erythematosus	3.6e-05	0.00029	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—TNF—systemic lupus erythematosus	3.58e-05	0.00112	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	3.56e-05	0.00111	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	3.54e-05	0.0011	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.53e-05	0.0011	CbGpPWpGaD
Telmisartan—Asthenia—Methotrexate—systemic lupus erythematosus	3.51e-05	0.000283	CcSEcCtD
Telmisartan—Nausea—Prednisone—systemic lupus erythematosus	3.47e-05	0.00028	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—systemic lupus erythematosus	3.46e-05	0.000279	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	3.45e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	3.4e-05	0.00106	CbGpPWpGaD
Telmisartan—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.34e-05	0.00027	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	3.32e-05	0.00104	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	3.3e-05	0.00103	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.28e-05	0.00103	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	3.25e-05	0.00102	CbGpPWpGaD
Telmisartan—Dizziness—Methotrexate—systemic lupus erythematosus	3.23e-05	0.00026	CcSEcCtD
Telmisartan—AGTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	3.23e-05	0.00101	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	3.18e-05	0.000994	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—EP300—systemic lupus erythematosus	3.12e-05	0.000974	CbGpPWpGaD
Telmisartan—Vomiting—Methotrexate—systemic lupus erythematosus	3.11e-05	0.00025	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.1e-05	0.000968	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—JAK1—systemic lupus erythematosus	3.09e-05	0.000965	CbGpPWpGaD
Telmisartan—Rash—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000248	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000248	CcSEcCtD
Telmisartan—PPARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	3.07e-05	0.000958	CbGpPWpGaD
Telmisartan—Headache—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000247	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—NAT2—systemic lupus erythematosus	3.06e-05	0.000955	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.01e-05	0.000941	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2.99e-05	0.000936	CbGpPWpGaD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—systemic lupus erythematosus	2.93e-05	0.000917	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	2.93e-05	0.000915	CbGpPWpGaD
Telmisartan—Nausea—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000234	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—IL6—systemic lupus erythematosus	2.89e-05	0.000904	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	2.89e-05	0.000903	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	2.84e-05	0.000886	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.84e-05	0.000886	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.68e-05	0.000837	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.62e-05	0.000817	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	2.61e-05	0.000815	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NAT2—systemic lupus erythematosus	2.61e-05	0.000815	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	2.6e-05	0.000812	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	2.57e-05	0.000804	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.54e-05	0.000793	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	2.46e-05	0.000767	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.45e-05	0.000764	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	2.44e-05	0.000762	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.43e-05	0.000759	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	2.4e-05	0.000751	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	2.39e-05	0.000746	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	2.38e-05	0.000744	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	2.37e-05	0.000741	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.34e-05	0.00073	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.33e-05	0.000727	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.28e-05	0.000711	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	2.25e-05	0.000704	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.21e-05	0.000692	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.18e-05	0.000682	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.18e-05	0.000682	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	2.16e-05	0.000676	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—JUNB—systemic lupus erythematosus	2.14e-05	0.00067	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	2.1e-05	0.000658	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.09e-05	0.000654	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.08e-05	0.000649	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—systemic lupus erythematosus	2.04e-05	0.000638	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TYK2—systemic lupus erythematosus	2.03e-05	0.000635	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.91e-05	0.000597	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.91e-05	0.000596	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	1.9e-05	0.000594	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	1.9e-05	0.000593	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	1.88e-05	0.000587	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	1.87e-05	0.000585	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.86e-05	0.000582	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.78e-05	0.000556	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	1.73e-05	0.000539	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	1.71e-05	0.000535	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—systemic lupus erythematosus	1.7e-05	0.000532	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.69e-05	0.000529	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.63e-05	0.000509	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	1.6e-05	0.0005	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.59e-05	0.000496	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.54e-05	0.000481	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.54e-05	0.00048	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	1.53e-05	0.000479	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	1.52e-05	0.000474	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.49e-05	0.000464	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RXRA—systemic lupus erythematosus	1.46e-05	0.000457	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.46e-05	0.000455	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	1.44e-05	0.000449	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.41e-05	0.00044	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.38e-05	0.000431	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.36e-05	0.000424	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.34e-05	0.00042	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.33e-05	0.000414	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	1.32e-05	0.000412	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.31e-05	0.000409	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.29e-05	0.000404	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.29e-05	0.000403	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.28e-05	0.0004	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.28e-05	0.0004	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	1.28e-05	0.000399	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	1.23e-05	0.000385	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.23e-05	0.000384	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.21e-05	0.000379	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	1.12e-05	0.000351	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.11e-05	0.000348	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	1.08e-05	0.000338	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.08e-05	0.000336	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	1.07e-05	0.000333	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.05e-05	0.000329	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.04e-05	0.000325	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.000321	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1e-05	0.000312	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	9.94e-06	0.000311	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	9.72e-06	0.000304	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	9.3e-06	0.000291	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	9.08e-06	0.000284	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	8.91e-06	0.000279	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	8.51e-06	0.000266	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.37e-06	0.000261	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—systemic lupus erythematosus	8.3e-06	0.000259	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—systemic lupus erythematosus	7.94e-06	0.000248	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.72e-06	0.000241	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	7.56e-06	0.000236	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.52e-06	0.000235	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	7.52e-06	0.000235	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	7.26e-06	0.000227	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.15e-06	0.000223	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.13e-06	0.000223	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	7.08e-06	0.000221	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.98e-06	0.000218	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	6.78e-06	0.000212	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	6.73e-06	0.00021	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.58e-06	0.000206	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.42e-06	0.000201	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—systemic lupus erythematosus	6.05e-06	0.000189	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—systemic lupus erythematosus	6.04e-06	0.000189	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	5.9e-06	0.000184	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.89e-06	0.000184	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	5.79e-06	0.000181	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	5.76e-06	0.00018	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.48e-06	0.000171	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	5.29e-06	0.000165	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	4.44e-06	0.000139	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—systemic lupus erythematosus	4.4e-06	0.000138	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	3.73e-06	0.000116	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	3.64e-06	0.000114	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	3.35e-06	0.000105	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.27e-06	0.000102	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	3.21e-06	0.0001	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.13e-06	9.78e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	2.93e-06	9.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.86e-06	8.94e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	2.44e-06	7.62e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.38e-06	7.44e-05	CbGpPWpGaD
